Cytidine-13C9

Cytidine-13C9 (Cytosine β-D-riboside-13C9) is 13C labeled Cytidine (HY-B0158) . Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function[1][2][3].

Product Specifications

Product Name Alternative

Cytosine β-D-riboside-13C9; Cytosine-1-β-D-ribofuranoside-13C9

UNSPSC

12352005

Target

Endogenous Metabolite; Isotope-Labeled Compounds; Nucleoside Antimetabolite/Analog

Type

Isotope-Labeled Compounds

Related Pathways

Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Others

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/cytidine-13c9.html

Concentration

100 mM in 39.6 μL Tris HCl/H2O buffer pH=7.5

Purity

99.10

Solubility

H2O : 50 mg/mL (ultrasonic;warming)

Smiles

O[13C@H]1[13CH](O)[13C@H](N2[13C](N=[13C](N)[13CH]=[13CH]2)=O)O[13C@@H]1[13CH2]O

Molecular Formula

13C9H13N3O5

Molecular Weight

252.15

References & Citations

[1]Jonas DA, et al. Safety considerations of DNA in food. Ann Nutr Metab. 2001;45 (6) :235-54.|[2]Wurtman RJ, et al. Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem Pharmacol. 2000 Oct 1;60 (7) :989-92.|[3]Machado-Vieira R, et, al. New therapeutic targets for mood disorders. ScientificWorldJournal. 2010 Apr 13;10:713-26.